Sotera Health Company

NasdaqGS:SHC 株式レポート

時価総額:US$3.4b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Sotera Health 将来の成長

Future 基準チェック /46

Sotera Health利益と収益がそれぞれ年間38.3%と5.9%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に37.6% 37.7%なると予測されています。

主要情報

38.3%

収益成長率

37.7%

EPS成長率

Life Sciences 収益成長16.7%
収益成長率5.9%
将来の株主資本利益率37.6%
アナリストカバレッジ

Good

最終更新日05 Jun 2024

今後の成長に関する最新情報

Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

Mar 01
Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

Recent updates

Sotera Health Company (NASDAQ:SHC) Shares Could Be 42% Below Their Intrinsic Value Estimate

May 30
Sotera Health Company (NASDAQ:SHC) Shares Could Be 42% Below Their Intrinsic Value Estimate

The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%

Mar 21
The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%

Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

Mar 01
Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

McIntyre Partnerships - Sotera Health Company: A Notable Outlier At A Discount

Feb 08

Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Feb 06
Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump

Dec 28
Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump

Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price

Dec 11
Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price

An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued

Sep 10
An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued

Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate

Jun 05
Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?

Feb 13
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?

Market Participants Recognise Sotera Health Company's (NASDAQ:SHC) Earnings Pushing Shares 29% Higher

Nov 24
Market Participants Recognise Sotera Health Company's (NASDAQ:SHC) Earnings Pushing Shares 29% Higher

Sotera Health plunges 20% after jury awards $363M against its Sterigenics unit

Sep 19

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 49%?

Sep 08
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 49%?

Sotera Health GAAP EPS of $0.11 misses by $0.05, revenue of $266.64M beats by $10.34M

Aug 04

Is Sotera Health Company (NASDAQ:SHC) Trading At A 46% Discount?

May 09
Is Sotera Health Company (NASDAQ:SHC) Trading At A 46% Discount?

Returns On Capital Are Showing Encouraging Signs At Sotera Health (NASDAQ:SHC)

Mar 16
Returns On Capital Are Showing Encouraging Signs At Sotera Health (NASDAQ:SHC)

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 38%?

Jan 19
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 38%?

業績と収益の成長予測

NasdaqGS:SHC - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20261,263173301N/A3
12/31/20251,1781382783127
12/31/20241,103932072547
3/31/20241,07755-377-172N/A
12/31/20231,04951-363-148N/A
9/30/2023991-306-381-159N/A
6/30/2023976-268-342-133N/A
3/31/2023988-26170262N/A
12/31/20221,004-23496278N/A
9/30/202299312190242N/A
6/30/2022971123127256N/A
3/31/2022956135159275N/A
12/31/2021931115179282N/A
9/30/202190736156237N/A
6/30/20218819127202N/A
3/31/2021842-26110171N/A
12/31/2020818-3967121N/A
9/30/2020795-2355109N/A
6/30/2020790-2868124N/A
3/31/2020772-2958116N/A
12/31/2019778-2192149N/A
12/31/2018746-647120N/A

アナリストによる今後の成長予測

収入対貯蓄率: SHCの予測収益成長率 (年間38.3% ) は 貯蓄率 ( 2.4% ) を上回っています。

収益対市場: SHCの収益 ( 38.3% ) はUS市場 ( 14.8% ) よりも速いペースで成長すると予測されています。

高成長収益: SHCの収益は今後 3 年間で 大幅に 増加すると予想されています。

収益対市場: SHCの収益 ( 5.9% ) US市場 ( 8.7% ) よりも低い成長が予測されています。

高い収益成長: SHCの収益 ( 5.9% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: SHCの 自己資本利益率 は、3年後には高くなると予測されています ( 37.6 %)


成長企業の発掘